In NSCLC cells, activation of M3R can promote cell proliferation and invasion via the epidermal growth factor receptor (EGFR)/phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway (17). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.